Tempest Therapeutics, Inc. Temporary Equity, Liquidation Preference
Tempest Therapeutics, Inc. (TPST) had Temporary Equity, Liquidation Preference of $100.19 million as of 2021-12-31, per its 10-Q filed 2022-05-13.
Discontinued › Balance Sheet › Equity › Temporary Equity › Temporary Equity, Other Disclosure
us-gaap:TemporaryEquityLiquidationPreference · last filed 2023-03-22
- 2021-12-31: Temporary Equity, Liquidation Preference $100.19M.
- 2021-06-25: Temporary Equity, Liquidation Preference $100.19M.
- 2020-12-31: Temporary Equity, Liquidation Preference $100.19M.
| Period end | Temporary Equity, Liquidation Preference |
|---|---|
| 2021-12-31 | $100.19M 10-Q · filed 2022-05-13 |
| 2021-06-25 | $100.19M 10-K · filed 2023-03-22 |
| 2020-12-31 | $100.19M 10-K · filed 2023-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |